XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
Preferred Stock [Member]
Convertible Preferred Stock [Member]
Common Stock [Member]
Treasury Stock, Common [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Noncontrolling Interest [Member]
Total
Balance at Jun. 30, 2023 $ 1,942 $ (1) $ 46,180,112 $ (41,807,573) $ (575,496) $ (111,986) $ 3,686,998
Balance, shares at Jun. 30, 2023 194,200            
Balance, shares at Jun. 30, 2023     (116)          
Foreign currency translation gain (loss) (18,016) (18,016)
Net loss (2,425,204) (7,220) (2,432,424)
Balance at Sep. 30, 2023 $ 1,942 $ (1) 46,180,112 (44,232,777) (593,512) (119,206) 1,236,558
Balance, shares at Sep. 30, 2023 194,200            
Balance, shares at Sep. 30, 2023     (116)          
Balance at Jun. 30, 2023 $ 1,942 $ (1) 46,180,112 (41,807,573) (575,496) (111,986) 3,686,998
Balance, shares at Jun. 30, 2023 194,200            
Balance, shares at Jun. 30, 2023     (116)          
Foreign currency translation gain (loss)               (86,909)
Net loss               (7,395,572)
Balance at Mar. 31, 2024 $ 29,135 $ (1) 60,946,174 (49,180,085) (662,405) (135,046) 10,997,772
Balance, shares at Mar. 31, 2024 2,913,799            
Balance, shares at Mar. 31, 2024     (116)          
Balance at Sep. 30, 2023 $ 1,942 $ (1) 46,180,112 (44,232,777) (593,512) (119,206) 1,236,558
Balance, shares at Sep. 30, 2023 194,200            
Balance, shares at Sep. 30, 2023     (116)          
Issuance of common stock upon cashless exercise of warrants $ 6,122 (6,122)
Issuance of common stock upon cashless exercise of warrants, shares 612,182            
Foreign currency translation gain (loss) 75,133 75,133
Net loss (1,969,641) (6,742) (1,976,383)
Issuance of common stock, Series E Preferred Stock and warrants, net of issuance costs $ 57,287 $ 1,860 3,727,017 3,786,164
Issuance of common stock, Series E preferred stock and warrants, net of issuance costs, shares 5,728,723 186,018            
Conversion of convertible preferred shares into common stock $ (57,287) $ 4,774 52,513
Conversion of convertible preferred shares into common stock, shares (5,728,723) 477,394            
Conversion of holdback Series C Preferred Stock into common stock $ 62 32,700 32,762
Conversion of holdback Series C Preferred Stock into common stock, shares 6,248            
Balance at Dec. 31, 2023 $ 14,760 $ (1) 49,986,220 (46,202,418) (518,379) (125,948) 3,154,234
Balance, shares at Dec. 31, 2023 1,476,042            
Balance, shares at Dec. 31, 2023     (116)          
Issuance of restricted stock to vendors $ 428 204,393 204,821
Issuance of restricted stock to vendors, shares   42,760            
Foreign currency translation gain (loss) (144,026) (144,026)
Net loss (2,977,667) (9,098) (2,986,765)
Reverse stock split rounding adjustment $ 475 (475)
Reverse stock split rounding adjustment, shares   47,501            
Issuance of common stock upon cash exercise of Series E warrants $ 6,291 1,645,207 1,651,498
Issuance of common stock upon cash exercise of Series E warrants, shares   629,409            
Issuance of common stock upon cashless exercise of Series F warrants $ 429 429
Issuance of common stock upon cashless exercise of Series F warrants, shares   42,904            
Issuance of common stock, Series I, H1 and H2 warrants, net of issuance costs $ 6,752 9,110,829 9,117,581
Issuance of common stock, Series I, H1 and H2 warrants, net of issuance costs, shares   675,183            
Balance at Mar. 31, 2024 $ 29,135 $ (1) 60,946,174 (49,180,085) (662,405) (135,046) 10,997,772
Balance, shares at Mar. 31, 2024 2,913,799            
Balance, shares at Mar. 31, 2024     (116)          
Balance at Jun. 30, 2024 $ 34,557 $ (1) 60,971,740 (51,964,332) (712,614) (146,159) $ 8,183,191
Balance, shares at Jun. 30, 2024 3,456,000            
Balance, shares at Jun. 30, 2024     (116)         116
Issuance of common stock upon cashless exercise of warrants $ 7,939 $ 7,939
Issuance of common stock upon cashless exercise of warrants, shares   793,930            
Stock awards issued to employees $ 995 189,050 190,045
Stock awards issued to employees, shares   99,500            
Issuance of restricted stock to vendors $ 112 11,888 12,000
Issuance of restricted stock to vendors, shares   11,162            
Issuance of common stock, net of issuance costs $ 172 34,339 34,511
Issuance of common stock, net of issuance costs, shares   17,167            
Foreign currency translation gain (loss) 216,355 216,355
Net loss (2,685,633) (9,166) (2,694,799)
Balance at Sep. 30, 2024 $ 43,775 $ (1) 61,207,017 (54,649,965) (496,259) (155,325) 5,949,242
Balance, shares at Sep. 30, 2024 4,377,759            
Balance, shares at Sep. 30, 2024     (116)          
Balance at Jun. 30, 2024 $ 34,557 $ (1) 60,971,740 (51,964,332) (712,614) (146,159) $ 8,183,191
Balance, shares at Jun. 30, 2024 3,456,000            
Balance, shares at Jun. 30, 2024     (116)         116
Issuance of common stock upon cashless exercise of warrants               $ 7,939
Issuance of common stock upon cashless exercise of warrants, shares               794,555
Stock awards issued to employees               $ 190,045
Foreign currency translation gain (loss)               189,197
Net loss               (7,502,270)
Balance at Mar. 31, 2025 $ 67,941 $ (1) 65,012,004 (59,442,961) (523,417) (169,800) $ 4,943,766
Balance, shares at Mar. 31, 2025 6,794,395            
Balance, shares at Mar. 31, 2025     (116)         116
Balance at Sep. 30, 2024 $ 43,775 $ (1) 61,207,017 (54,649,965) (496,259) (155,325) $ 5,949,242
Balance, shares at Sep. 30, 2024 4,377,759            
Balance, shares at Sep. 30, 2024     (116)          
Issuance of restricted stock to vendors $ 81 11,919 12,000
Issuance of restricted stock to vendors, shares   8,109            
Issuance of common stock, net of issuance costs $ 4,212 637,896 642,108
Issuance of common stock, net of issuance costs, shares   421,200            
Foreign currency translation gain (loss) (143,165) (143,165)
Net loss (2,249,470) (7,327) (2,256,797)
Balance at Dec. 31, 2024 $ 48,068 $ (1) 61,856,832 (56,899,435) (639,424) (162,652) 4,203,388
Balance, shares at Dec. 31, 2024 4,807,068            
Balance, shares at Dec. 31, 2024     (116)          
Issuance of common stock upon cashless exercise of warrants $ 6 (6)
Issuance of common stock upon cashless exercise of warrants, shares   625            
Issuance of restricted stock to vendors $ 47 11,953 12,000
Issuance of restricted stock to vendors, shares   4,706            
Issuance of common stock, net of issuance costs $ 19,820 3,143,225 $ 3,163,045
Issuance of common stock, net of issuance costs, shares   1,981,996           481,996
Foreign currency translation gain (loss) 116,007 $ 116,007
Net loss (2,543,526) (7,148) (2,550,674)
Foreign currency translation gain, shares              
Balance at Mar. 31, 2025 $ 67,941 $ (1) $ 65,012,004 $ (59,442,961) $ (523,417) $ (169,800) $ 4,943,766
Balance, shares at Mar. 31, 2025 6,794,395            
Balance, shares at Mar. 31, 2025     (116)         116